Elevance Health Inc
$ 333.49
0.83%
04 Dec - close price
- Market Cap 75,094,712,000 USD
- Current Price $ 333.49
- High / Low $ 336.45 / 328.31
- Stock P/E 13.59
- Book Value 197.95
- EPS 24.54
- Next Earning Report 2026-01-22
- Dividend Per Share $6.76
- Dividend Yield 2.04 %
- Next Dividend Date 2025-12-19
- ROA 0.04 %
- ROE 0.13 %
- 52 Week High 454.26
- 52 Week Low 272.22
About
Elevance Health Inc. is a leading health benefits provider based in Indianapolis, Indiana, specializing in a diverse portfolio of health insurance and wellness services. The company leverages advanced data analytics and technology to deliver personalized care solutions, significantly enhancing consumer health outcomes. Elevance operates across multiple sectors, including individual and group insurance, with a strong focus on value-based care to adapt to the evolving needs of its members. Additionally, through strategic acquisitions and partnerships, Elevance is solidifying its position as an innovative leader in the healthcare industry, dedicated to improving efficiency and transforming health interactions.
Analyst Target Price
$387.16
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-21 | 2025-07-17 | 2025-04-22 | 2025-01-23 | 2024-10-17 | 2024-07-17 | 2024-04-18 | 2024-01-24 | 2023-10-18 | 2023-07-19 | 2023-04-19 | 2023-01-25 |
| Reported EPS | 6.03 | 7.72 | 11.97 | 3.84 | 8.37 | 10.12 | 10.64 | 5.62 | 8.99 | 9.04 | 9.46 | 5.23 |
| Estimated EPS | 4.94 | 8.54 | 11.48 | 3.85 | 9.65 | 10.01 | 10.53 | 5.59 | 8.46 | 8.78 | 9.28 | 5.19 |
| Surprise | 1.09 | -0.82 | 0.49 | -0.01 | -1.28 | 0.11 | 0.11 | 0.03 | 0.53 | 0.26 | 0.18 | 0.04 |
| Surprise Percentage | 22.0648% | -9.6019% | 4.2683% | -0.2597% | -13.2642% | 1.0989% | 1.0446% | 0.5367% | 6.2648% | 2.9613% | 1.9397% | 0.7707% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-01-22 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 3.2 |
| Currency | USD |
Previous Dividend Records
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-12-19 | 2025-09-25 | 2025-06-25 | 2025-03-25 | 2024-12-20 | 2024-09-25 | 2024-06-25 | 2024-03-22 | 2023-12-21 | 2023-09-22 |
| Amount | $1.71 | $1.71 | $1.71 | $1.71 | $1.63 | $1.63 | $1.63 | $1.63 | $1.48 | $1.48 |
Next Dividend Records
| Dividend per share (year): | $6.76 |
| Dividend Yield | 2.04% |
| Next Dividend Date | 2025-12-19 |
| Ex-Dividend Date | 2025-12-05 |
Recent News: ELV
2025-12-05 09:59:50
Brown Advisory Inc. reduced its stake in Elevance Health, Inc. (NYSE:ELV) by 6.7% in the second quarter, selling 28,706 shares and retaining 396,620 shares valued at $154.27 million. Despite this, other institutional investors like Commonwealth Equity Services LLC and Empower Advisory Group LLC increased their holdings. Elevance Health reported strong Q3 earnings, surpassing consensus estimates, and declared a quarterly dividend of $1.71 per share.
2025-12-05 08:50:32
Amundi significantly increased its stake in Elevance Health, Inc. by 29.5% in the second quarter, now owning 1,404,180 shares valued at over $546 million. This move is part of broader institutional investor activity, with several other hedge funds also adjusting their positions in the healthcare company. Elevance Health recently announced a quarterly dividend of $1.71 per share and reported strong quarterly earnings, beating analyst estimates.
2025-12-05 08:42:32
Beutel Goodman & Co Ltd. has acquired a significant new position in Elevance Health, Inc. (NYSE:ELV), purchasing 753,653 shares valued at approximately $293.14 million during the second quarter. This acquisition represents about 0.33% of the health benefits company. Elevance Health, which recently reported strong Q3 earnings beating analyst estimates, also declared a quarterly dividend of $1.71 per share.
2025-12-04 20:08:57
Centene (CNC) has cut its earnings guidance due to higher-than-expected medical utilization in its federal exchange plans and ongoing pressure in its Medicaid business. This adjustment raises concerns that potential changes to federal exchange subsidy policy could lead to a smaller, sicker enrollee base, putting additional pressure on profitability and reshaping Centene's investment narrative. The company's updated 2025 outlook now anticipates a GAAP diluted loss per share not exceeding US$12.85, impacting its short-term earnings recovery prospects.
2025-12-04 20:08:30
This article summarizes a bullish thesis on Molina Healthcare, Inc. (MOH) from Sherwood Investment Letter, highlighting that the market's 20% drop in share price after a disappointing Q3 was an overreaction. Despite short-term pressures, Molina's fundamentals remain resilient with 11% revenue growth, and its defensive position in Medicaid and Medicare suggests significant upside potential. The thesis posits that the current low price presents a value opportunity similar to past market dislocations.
2025-12-04 19:09:10
This article summarizes a bullish thesis on Molina Healthcare, Inc. (MOH) from Sherwood Investment Letter, suggesting its stock is undervalued after a significant drop following Q3 results. Despite short-term pressures, Molina shows resilient fundamentals with 11% revenue growth and a defensive operating model in the Medicaid and Medicare space. The author posits the market's reaction is an overcorrection, presenting a potential investment opportunity similar to when Berkshire Hathaway invested in UnitedHealth.
